国际肝胆胰疾病杂志（英文版）Issue(3)：316-318,3.DOI:10.1016/S1499-3872(16)60087-5
Anti-virus prophylaxis withdrawal may be feasible in liver transplant recipients whose serum HBeAg and HBV DNA are negative
Anti-virus prophylaxis withdrawal may be feasible in liver transplant recipients whose serum HBeAg and HBV DNA are negative
Lei Geng 1Bing-Yi Lin 2Tian Shen 1Hua Guo 1Yu-Fu Ye 1Shu-Sen Zheng1
作者信息
- 1. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Afifliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
- 2. Key Laboratory of Combined Multi-organ Trans-plantation, Ministry of Public Health, Key Laboratory of Organ Trans-plantation and Collaborative Innovation Center for Diagnosis Treatment of Infectious Diseases, Hangzhou 310003, China
- 折叠
摘要
关键词
anti-virus prophylaxis withdrawal/HBeAg/HBV DNA/liver transplantationKey words
anti-virus prophylaxis withdrawal/HBeAg/HBV DNA/liver transplantation引用本文复制引用
Lei Geng,Bing-Yi Lin,Tian Shen,Hua Guo,Yu-Fu Ye,Shu-Sen Zheng..Anti-virus prophylaxis withdrawal may be feasible in liver transplant recipients whose serum HBeAg and HBV DNA are negative[J].国际肝胆胰疾病杂志（英文版）,2015,(3):316-318,3.
